摘要
目的:探讨癌胚抗原(CEA)和鳞状细胞癌抗原(SCC-Ag)血清水平联合检测对宫颈癌患者的临床诊断、分期、分型,病理类型和疗效观察的价值。方法:采用酶联免疫吸附法(ELISA)以100名健康人做对照,检测217例宫颈癌患者,其中手术或放射治疗后119例CEA与SCC-Ag血清水平。结果:宫颈癌患者CEA与SCC-Ag血清水平明显高于健康人,P<0.01;SCC-Ag检测宫颈癌的敏感度、准确度和阴性预测值明显高于CEA,均P<0.01;宫颈癌分期(0期-Ⅲ期)CEA和SCC-Ag血清水平组间比较,均P<0.01;宫颈癌分型(糜烂型、外生型、内生型和溃疡型)CEA和SCC-Ag血清水平组间比较,均P<0.01;治疗后缓解(CR+PR)的患者CEA和SCC-Ag血清水平明显下降,P<0.01,未缓解(MR+PD)的患者明显升高,P<0.05。另外,在检测的5例宫颈腺癌患者中有4例CEA血清水平高于界值,2例SCC-Ag高于界值。结论:宫颈癌患者CEA和SCC-Ag血清水平均明显升高,SCC-Ag对宫颈癌的诊断要优于CEA,而CEA对宫颈腺癌的诊断可能是一个良好的指标。两项检测对宫颈癌的分期,分型均有临床指导意义,特别是对宫颈癌的疗效观察作用明显,有重要的参考价值。
Objective:To study the clinical characteristics of CEA and SCC -Ag in patients with cervical cancer. Methods:Serum level of CEA and SCC -Ag was measured by ELISA in 217 patients with cervical cancer, and 100 healthy subjects, 119 patients with cervical cancer before and after treatment were also measured. Results:The serum level of CEA and SCC - Ag significantly increased in patients with cervical cancer as compared to that of the healthy subjects( P 〈 0.01 ). The sensitivity, accuracy and NPV of diagnosis with SCC -Ag in cervical cancer patients was significantly higher than that with CEA( P 〈0. Ol ). Among the four stages(O - Ⅲ ) ,the serum levels of CEA and SCC - Ag were significantly different( P 〈 0.01 ), among the four morphologys ( erosive, Exogenous, Endogenous and ulcerative types), the serum levels of CEA and SCC - Ag in erosive cervical cancer was significantly lower than that in the other three groups( P 〈0.01 ). In 88 patients with belief after treatment the levels of CEA and SCC - Ag was sig- nificantly lower than that before treatment, but in the 31 patients without belief the levels were significantly higher than that before treatment. In addition, in 5 patients with cervical adenomatous carcinoma, there was 4 patients that the CEA was higher than the cut - off value,and only 2 patients that the SCC - Ag was higher than the cut - off value. Conclusion: The serum levels of CEA and SCC - Ag in patients with cervical cancer were both increased. SCC - Ag is a more sensitive marker than CEA for the diagnosis of cervical cancer. CEA maybe a good marker for cervical adenom- atous carcinoma. Both of the two markers is useful for cervical carcinoma staging and typing, especially for treatment assessment.
出处
《现代肿瘤医学》
CAS
2013年第10期2316-2318,共3页
Journal of Modern Oncology